PMID- 16960104 OWN - NLM STAT- MEDLINE DCOM- 20061113 LR - 20220224 IS - 1524-4636 (Electronic) IS - 1079-5642 (Linking) VI - 26 IP - 11 DP - 2006 Nov TI - Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. PG - 2483-9 AB - OBJECTIVE: Monocyte chemoattractant protein-1 (MCP-1) is a C-C chemokine that is known as an inflammatory/arteriogenic factor. Angiogenesis contributes to the inflammatory process; however, the molecular and cellular mechanisms of the links among the inflammatory pathway, arteriogenesis, and angiogenesis have not been well elucidated. METHODS AND RESULTS: Using murine models of fibroblast growth factor-2 (FGF-2)-mediated therapeutic neovascularization, we here show that FGF-2 targets nonendothelial mesenchymal cells (NEMCs) enhancing both angiogenic (vascular endothelial growth factor [VEGF]) and arteriogenic (MCP-1) signals via independent signal transduction pathways. Severe hindlimb ischemia stimulated MCP-1 expression that was strongly enhanced by FGF-2 gene transfer, and a blockade of MCP-1 activity via a dominant negative mutant as well as a deficiency of its functional receptor CCR2 resulted in the diminished recovery of blood flow attributable to adaptive and therapeutic neovascularization. Tumor necrosis factor (TNF)-alpha stimulated MCP-1 expression in all cell types tested, whereas FGF-2-mediated upregulation of MCP-1 was found only in NEMCs but not in others, a finding that was not affected by VEGF in vitro and in vivo. CONCLUSIONS: These results indicate that FGF-2 targets NEMCs independently, enhancing both angiogenic (VEGF) as well as inflammatory/arteriogenic (MCP-1) pathways. Therefore, MCP-1/CCR2 plays a critical role in adaptive and FGF-2-mediated therapeutic neovascularization. FAU - Fujii, Takaaki AU - Fujii T AD - Division of Pathophysiological and Experimental Pathology, Department of Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. FAU - Yonemitsu, Yoshikazu AU - Yonemitsu Y FAU - Onimaru, Mitsuho AU - Onimaru M FAU - Tanii, Mitsugu AU - Tanii M FAU - Nakano, Toshiaki AU - Nakano T FAU - Egashira, Kensuke AU - Egashira K FAU - Takehara, Takako AU - Takehara T FAU - Inoue, Makoto AU - Inoue M FAU - Hasegawa, Mamoru AU - Hasegawa M FAU - Kuwano, Hiroyuki AU - Kuwano H FAU - Sueishi, Katsuo AU - Sueishi K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060907 PL - United States TA - Arterioscler Thromb Vasc Biol JT - Arteriosclerosis, thrombosis, and vascular biology JID - 9505803 RN - 0 (Ccr2 protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Inflammation Mediators) RN - 0 (NF-kappa B) RN - 0 (Receptors, CCR2) RN - 0 (Receptors, Chemokine) RN - 0 (Vascular Endothelial Growth Factor A) RN - 103107-01-3 (Fibroblast Growth Factor 2) RN - EC 2.7.11.13 (Protein Kinase C) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) SB - IM MH - Adaptation, Physiological MH - Animals MH - Arteries/growth & development MH - Chemokine CCL2/*metabolism MH - Fibroblast Growth Factor 2/genetics/*metabolism MH - Gene Transfer Techniques MH - Hindlimb/blood supply MH - Inflammation Mediators/metabolism MH - Ischemia/metabolism/physiopathology MH - Male MH - Mesoderm/*cytology/*metabolism MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Mitogen-Activated Protein Kinases/metabolism MH - NF-kappa B/metabolism MH - *Neovascularization, Physiologic MH - Protein Kinase C/metabolism MH - Receptors, CCR2 MH - Receptors, Chemokine/metabolism MH - Regional Blood Flow MH - Signal Transduction MH - Vascular Endothelial Growth Factor A/metabolism EDAT- 2006/09/09 09:00 MHDA- 2006/11/14 09:00 CRDT- 2006/09/09 09:00 PHST- 2006/09/09 09:00 [pubmed] PHST- 2006/11/14 09:00 [medline] PHST- 2006/09/09 09:00 [entrez] AID - 01.ATV.0000244684.23499.bf [pii] AID - 10.1161/01.ATV.0000244684.23499.bf [doi] PST - ppublish SO - Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2483-9. doi: 10.1161/01.ATV.0000244684.23499.bf. Epub 2006 Sep 7.